Jump to navigation
The NDARC Webinar Series includes a compelling lineup of expert speakers, with topics including hepatitis C, drug and alcohol services and quit smoking medicines.
The CoLAB study, led by NDARC at UNSW Sydney, has been extended for 12 months to continue evaluating outcomes, processes and costs of extended release buprenorphine.
New NDRI-led research on the social and economic costs of ‘extra-medical’ opioid use has been published.
NCETA’s research has identified numerous challenges to worker wellbeing such as stigmatisation, clients with complex needs, and complex personal, family and community circumstances.
NCETA’s Professor Ann Roche was recently featured in the media highlighting the increased health risks of people using more drugs and alcohol to cope with stress, anxiety and boredom during COVID-1
In the first Australian study of its kind, 559 cannabis-related deaths identified between 2000 and 2018 have been examined by NDARC researchers.
The DNeT project has released new resources looking at trends in the availability and type of drugs sold on the internet via cryptomarkets.
The 2020 NDARC Seminar Series is continuing online via webinar.
NDARC is closely monitoring the COVID-19 pandemic and responding through new and existing research projects.
The ADAPT Study is exploring the short and long-term impacts of COVID-19 on Australians who use illicit drugs.
A new resource for service providers working with young Aboriginal women and girls
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Tuesday 3 May 2022